Global Markets for Research Antibodies

News provided by

Mar 10, 2015, 04:27 ET

NEW YORK, March 10, 2015 /PRNewswire/ -- REPORT HIGHLIGHTS

The global market for research antibodies reached $2 billion in 2013 and nearly $2.2 billion in 2014. This market is expected to reach nearly $3 billion in 2019, registering a compound annual growth rate (CAGR) of 6.2% for the period 2014-2019.

This report provides:

An overview of the global market for antibodies used in research.
Analyses of global market trends, with data from 2013, estimates for 2014, and projections of CAGRs through 2019.
Segmentation of the market by geography, product types, research applications, species, and major research area.
Details concerning end user types, purchasing factors, new market trends, and potential growth opportunities that are available.
Discussion on the factors affecting strategies of antibody companies, the effect of research funding, and third-party quality evaluation systems.
Analysis of the competitive landscape and key competitor market shares.

STUDY GOALS AND OBJECTIVES

The aim of this report is to provide detailed market and industry analyses to help readers quantify and qualify the global market for research antibodies. Important trends in the field and market segments are identified, and market sizes and sales forecasts by segmented markets are provided through 2019.
This report focuses on the market side rather than the technical side. The detailed market segmentation, market shares, major drivers, trend analysis and forecasts for the entire research antibody market are analyzed. In particular, this report includes:
l An overview of the global market for antibodies used in research.
l Analyses of global market trends, with data from 2013, estimates for 2014, and projections of compound annual growth rates (CAGRs) through 2019.
l Segmentation of the market by geography, product types, research applications, species and major research area.
l Details concerning end users, purchasing factors, new market trends and potential growth opportunities.
l Discussion of the factors affecting strategies of antibody companies, the effect of research funding and third-party quality evaluation systems.
l Analysis of the competitive landscape and market shares for the key players.
l Comprehensive company profiles of the major players in the research antibody field.

REASONS FOR DOING THIS STUDY

Detailed market and industry analysis for the research antibody market is needed. The research antibody market reports available are more focused on analysis of end users' surveys, customer needs and the overall antibody market. There is no detailed market segmentation and trend analysis for each market segment.
In fact, the research antibody industry is also at a critical time for a revolutionary or breakthrough change. New technologies for antibody generations are emerging, and new research needs, including those for new targets, higher specificity and higher sensitivity, etc., are increasing. More importantly, improving scientific reproducibility, including improving the lot-to-lot consistency of research reagents such as antibodies, is being emphasized by all related communities. Those antibody suppliers who hold proprietary technologies in making antibodies with the lot-to-lot consistency will probably be able to better meet the market needs. So, will the research antibody market stick with the current situation or will a breakthrough occur in the next five to ten years? Are there still any opportunities for new entries in a market that has been crowded with hundreds of big and small suppliers? How much will the current competitive landscape of the research antibody market change over the next five years? This report will provide useful information, analysis and forecasts to help you find the answers to these questions.

Since the first generation of monoclonal antibodies in 1975, the antibody industry has evolved to a prosperous one today. The research sector of the antibody industry is the smallest of the three sectors of the antibody industry, the other two being the diagnostic and therapeutic sectors. However, the research antibody sector is a foundation of the other two. To some degree, detailed analysis of research sectors will also bring about some key hints in the market directions of the diagnostic and therapeutic sectors.
The information in this report can help all antibody suppliers better understand the overall antibody market and the segment of the market they focus on. The detailed analysis and forecasts of the research antibody market can provide useful information for all management levels to help make strategic decisions in related areas.

SCOPE OF REPORT

This study focuses on the market side of research antibodies rather than the technical side. Different market segments for this specific market are covered. For example, application-based market segments include enzyme-linked immunosorbent assay (ELISA), western blotting (WB), immunohistochemistry (IHC), immunofluorescent staining (IF) and flow cytometry (FC); antibody function-based market segments include primary antibodies and secondary antibodies; antibody clonality-based market segments include polyclonal antibodies and monoclonal antibodies, including oligoclonal antibodies; customer type-based market segments include universities/academic institutions, pharmaceutical/biotech companies and other types of customers such as governmental research labs and CROs; geography-based market segments include the U.S., Europe, Asia-Pacific and Rest of World. Research and market trends are also extrapolated by analyzing the funding, patent publications and sales trends of major players in the field.
Read the full report: http://www.reportlinker.com/p02669411-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com